Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis

导出原文传递

翻译打印收藏纠错

作者： Clarke, Astrid S. ^[1] ; Rousseau, Emma ^[2] ; Wang, Kelly ^[3] ; Kim, Ji-Yun ^[4] ; Murray, Bernard P. ^[5] ; Bannister, Roy ^[6] ; Matzkies, Franziska ; Currie, Kevin S. ; Di Paolo, Julie A.

作者单位： Gilead Sci Inc, Drug Metab, 333 Lakeside Dr, Foster City, CA 94404 USA ^[1] Gilead Sci Inc, Clin Res, 333 Lakeside Dr, Foster City, CA 94404 USA ^[2] Gilead Sci Inc, Chem, 333 Lakeside Dr, Foster City, CA 94404 USA ^[3] Gilead Sci Inc, Biomarker Sci, 333 Lakeside Dr, Foster City, CA 94404 USA ^[4] Gilead Sci Inc, Biol, 333 Lakeside Dr, Foster City, CA 94404 USA ^[5] Gilead Sci Inc, Drug Safety Evaluat, 333 Lakeside Dr, Foster City, CA 94404 USA ^[6]

关键词 Bleeding time Glycoprotein VI receptor Hemostasis Nonsteroidal anti-inflammatory drugs (NSAIDs)Spleen tyrosine kinase (SYK)Platelet

发布时间 2019-09-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Thrombosis Research

2018年170卷

109-118页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis

Thrombosis Research

相似文献

Thrombosis Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis

Thrombosis Research

相似文献

Thrombosis Research

相关期刊

检索历史清除